Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
kdq6XFaYnqarS6sB